(Q40560930)

21 September 2017

title

A phase I pharmacokinetic and pharmacodynamic study of the DNA methyltransferase 1 inhibitor MG98 administered twice weekly (English)

1 reference

21 September 2017

1 reference

https://api.crossref.org/works/10.1093/ANNONC/MDG216

25 December 2023

1 reference

1 reference

D. J. Stewart

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12702532

25 December 2023

R. C. Donehower

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12702532

25 December 2023

E. A. Eisenhauer

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12702532

25 December 2023

N. Wainman

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12702532

25 December 2023

A. K. Shah

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12702532

25 December 2023

C. Bonfils

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12702532

25 December 2023

A. R. MacLeod

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12702532

25 December 2023

J. M. Besterman

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12702532

25 December 2023

G. K. Reid

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12702532

25 December 2023

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=12702532

25 December 2023

publication date

1 May 2003

1 reference

full work available at URL

21 September 2017

http://www.annalsofoncology.org/article/S0923753419635246/pdf

file format

Portable Document Format

online access status

open access

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12702532

https://api.elsevier.com/content/article/PII:S0923753419635246?httpAccept=text/xml

25 December 2023

1 reference

https://api.crossref.org/works/10.1093/ANNONC/MDG216

https://api.elsevier.com/content/article/PII:S0923753419635246?httpAccept=text/plain

25 December 2023

1 reference

https://api.crossref.org/works/10.1093/ANNONC/MDG216

http://academic.oup.com/annonc/article-pdf/14/5/766/569525/mdg216.pdf

25 December 2023

file format

Portable Document Format

1 reference

https://api.crossref.org/works/10.1093/ANNONC/MDG216

25 December 2023

1 reference

21 September 2017

volume

14

1 reference

21 September 2017

issue

5

1 reference

21 September 2017

page(s)

766-774

1 reference

DNA methyltransferases Dnmt3a and Dnmt3b are essential for de novo methylation and mammalian development

21 September 2017

cites work

1 reference

24 May 2022

https://opencitations.net/index/coci/api/v1/citations/10.1016/S0092-8674(00)81656-6

Genomic footprinting reveals cell type-specific DNA binding of ubiquitous factors

1

1 reference

https://api.crossref.org/works/10.1093/ANNONC/MDG216

DNA methyltransferase inhibitors-state of the art.

25 December 2023

2

1 reference

https://api.crossref.org/works/10.1093/ANNONC/MDG216

Oncogenes and tumor-suppressor genes

25 December 2023

3

1 reference

https://api.crossref.org/works/10.1093/ANNONC/MDG216

DNA methylation properties: consequences for pharmacology

25 December 2023

4

1 reference

https://api.crossref.org/works/10.1093/ANNONC/MDG216

5′ CpG island methylation is associated with transcriptional silencing of the tumour suppressor p16/CDKN2/MTS1 in human cancers

25 December 2023

5

1 reference

https://api.crossref.org/works/10.1093/ANNONC/MDG216

The DNA methylation machinery as a target for anticancer therapy

25 December 2023

6

1 reference

https://api.crossref.org/works/10.1093/ANNONC/MDG216

Expression of an exogenous eukaryotic DNA methyltransferase gene induces transformation of NIH 3T3 cells.

25 December 2023

8

1 reference

https://api.crossref.org/works/10.1093/ANNONC/MDG216

An essential role for DNA methyltransferase DNMT3B in cancer cell survival

25 December 2023

10

1 reference

https://api.crossref.org/works/10.1093/ANNONC/MDG216

DNMT1 and DNMT3b cooperate to silence genes in human cancer cells

25 December 2023

11

1 reference

https://api.crossref.org/works/10.1093/ANNONC/MDG216

Progress in antisense oligonucleotide therapeutics

25 December 2023

12

1 reference

https://api.crossref.org/works/10.1093/ANNONC/MDG216

Down-regulation of human DNA-(cytosine-5) methyltransferase induces cell cycle regulators p16(ink4A) and p21(WAF/Cip1) by distinct mechanisms

25 December 2023

13

1 reference

https://api.crossref.org/works/10.1093/ANNONC/MDG216

Antitumor effect of c-myc antisense phosphorothioate oligodeoxynucleotides on human melanoma cells in vitro and and in mice.

25 December 2023

16

1 reference

https://api.crossref.org/works/10.1093/ANNONC/MDG216

Active vs. passive resistance, dose-response relationships, high dose chemotherapy, and resistance modulation: a hypothesis

25 December 2023

17

1 reference

https://api.crossref.org/works/10.1093/ANNONC/MDG216

Synthetic oligonucleotides: the development of antisense therapeutics

25 December 2023

19

1 reference

https://api.crossref.org/works/10.1093/ANNONC/MDG216

25 December 2023

Identifiers

1 reference

21 September 2017

1 reference